How is Morquio Syndrome diagnosed?

Morquio Syndrome is diagnosed through a combination of clinical physical examination, urine analysis for specific glycosaminoglycans (GAGs), and confirmatory genetic testing to identify mutations in the GALNS or GLB1 genes.

The Diagnostic Journey

I understand that for many families, the path to a Morquio Syndrome diagnosis is often long and exhausting. This "diagnostic odyssey" frequently involves visiting multiple specialists before the condition is identified, as the initial symptoms—such as skeletal abnormalities, joint laxity, or growth delays—can be subtle in early childhood. Validating your frustration is important; you are not alone in this struggle, and persistence in seeking answers is essential.

Clinical Evaluation and Testing

The diagnostic process typically begins with a physical examination by a pediatrician or orthopedist who notices skeletal irregularities. Key steps include:

• Urine Analysis: A quantitative test for keratan sulfate, which is typically elevated in patients with Morquio Syndrome.


• Enzyme Assay: Measuring the activity levels of the enzymes N-acetylgalactosamine-6-sulfatase (Type A) or beta-galactosidase (Type B) in white blood cells or skin fibroblasts.


• Genetic Testing: Molecular genetic testing confirms the diagnosis by identifying pathogenic variants in the GALNS or GLB1 genes.


• Imaging: X-rays often reveal characteristic skeletal findings, such as platyspondyly (flattened vertebrae) and hip dysplasia, which are hallmarks of Morquio Syndrome.

Specialized Care

Because Morquio Syndrome is a systemic condition, it is vital to consult with a metabolic specialist or a medical geneticist. These experts are best equipped to distinguish the condition from other skeletal dysplasias or mucopolysaccharidoses. If your primary care provider is unfamiliar with this rare disorder, do not hesitate to request a referral to a metabolic center of excellence. Early diagnosis is crucial for managing the complex needs of those living with Morquio Syndrome, as it allows for the timely initiation of supportive care and potential enzyme replacement therapies.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Online Mendelian Inheritance in Man (OMIM)


• National MPS Society